About Nathalie Grob
The Grob Group focuses on designing and screening potential therapeutic modalities that address common challenges faced by peptide drugs. We develop workflows for affinity-based screening of combinatorial libraries, leveraging mass spectrometry to identify drug scaffolds with enhanced pharmacokinetic and pharmacodynamic properties. Our research concentrates on the modulation of protein-protein interactions with relevance to diseases and conditions related to women’s health.
Nathalie Grob is an Assistant Professor at the ETHZ since April 2024 supported by a starting Grant of the SNSF.
Contact
Grob’s research lab website